Seizing market shaping opportunities for vaccine cold chain equipment
- PMID: 28364940
- DOI: 10.1016/j.vaccine.2016.12.073
Seizing market shaping opportunities for vaccine cold chain equipment
Abstract
Gavi, the Vaccine Alliance, supports immunisation programmes in eligible countries to reach children with lifesaving vaccines. Dramatic improvement in the scale and performance of current cold chain systems is required to extend the reach of immunisation services - especially for children living in remote locations - to advance progress towards full vaccine coverage. Achieving these improvements will require a healthier market for cold chain equipment where the products meet user needs, are sustainably priced, and are available in sufficient quantities to meet demand. Yet evidence suggests that the cold chain market has suffered from several failures including limited demand visibility, fragmented procurement, and insufficient information exchange between manufacturers and buyers on needs and equipment performance. One of Gavi's strategic goals is to shape markets for vaccines and other immunisation products, including cold chain equipment and in 2015, Gavi created a new mechanism - the Cold Chain Equipment (CCE) Optimisation Platform - to strengthen country cold chain systems by offering financial support and incentives for higher performing CCE. The main objective of the CCE Platform is to get more equipment that is efficient, sustainable, and better performing deployed to every health facility where it is required at an affordable price. To achieve these objectives, Gavi is putting in place tested market shaping approaches and tools adapted for the CCE market: the development of market strategies or 'roadmaps'; improvement of product performance through the development of target product profiles (TPPs); strategic engagement with CCE manufacturers and countries to enhance information sharing; and tailoring procurement tactics to the CCE market. These approaches and tools will allow for increased demand and supply of higher-performing, cost-effective and quality products. By strengthening immunisation systems with improved cold chain equipment, Gavi countries can begin to address the underlying problems limiting vaccine availability and improve the coverage and equity of vaccines.
Keywords: Cold chain equipment; Market shaping; Supply chain; Target product profile; Vaccine.
Copyright © 2017 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
Root cause analysis underscores the importance of understanding, addressing, and communicating cold chain equipment failures to improve equipment performance.Vaccine. 2017 Apr 19;35(17):2198-2202. doi: 10.1016/j.vaccine.2016.09.068. Vaccine. 2017. PMID: 28364931 Free PMC article.
-
Shaping markets to benefit global health - A 15-year history and lessons learned from the pentavalent vaccine market.Vaccine X. 2019 Jul 18;2:100033. doi: 10.1016/j.jvacx.2019.100033. eCollection 2019 Aug 9. Vaccine X. 2019. PMID: 31384748 Free PMC article. Review.
-
Innovations in cold chain equipment for immunization supply chains.Vaccine. 2017 Apr 19;35(17):2252-2259. doi: 10.1016/j.vaccine.2016.11.094. Vaccine. 2017. PMID: 28364939 Review.
-
Deployment of vaccine cold chain equipment in resource-limited settings: lessons from the Gavi Cold Chain Optimization Platform in Cameroon.Int Health. 2025 Jan 3;17(1):33-40. doi: 10.1093/inthealth/ihae010. Int Health. 2025. PMID: 38333954 Free PMC article.
-
A Tale of 2 Countries: Implementation of the Cold Chain Equipment Optimization Platform in Guinea and Kenya.Glob Health Sci Pract. 2022 Oct 31;10(5):e2200066. doi: 10.9745/GHSP-D-22-00066. Print 2022 Oct 31. Glob Health Sci Pract. 2022. PMID: 36316144 Free PMC article.
Cited by
-
The potential effects of deploying SARS-Cov-2 vaccines on cold storage capacity and immunization workload in countries of the WHO African Region.Vaccine. 2021 Apr 8;39(15):2165-2176. doi: 10.1016/j.vaccine.2021.02.037. Epub 2021 Feb 19. Vaccine. 2021. PMID: 33744049 Free PMC article.
-
The operational impact of deploying SARS-CoV-2 vaccines in countries of the WHO African Region.medRxiv [Preprint]. 2020 Nov 1:2020.08.13.20147595. doi: 10.1101/2020.08.13.20147595. medRxiv. 2020. Update in: Vaccine. 2021 Apr 8;39(15):2165-2176. doi: 10.1016/j.vaccine.2021.02.037. PMID: 32817984 Free PMC article. Updated. Preprint.
-
Immunization supply chains: Why they matter and how they are changing.Vaccine. 2017 Apr 19;35(17):2103-2104. doi: 10.1016/j.vaccine.2017.02.062. Vaccine. 2017. PMID: 28364914 Free PMC article. No abstract available.
-
Development of a Recombinant Thermostable Newcastle Disease Virus (NDV) Vaccine Express Infectious Bronchitis Virus (IBV) Multiple Epitopes for Protecting against IBV and NDV Challenges.Vaccines (Basel). 2020 Oct 1;8(4):564. doi: 10.3390/vaccines8040564. Vaccines (Basel). 2020. PMID: 33019497 Free PMC article.
-
Thermal Stabilization of Viral Vaccines in Low-Cost Sugar Films.Sci Rep. 2019 May 21;9(1):7631. doi: 10.1038/s41598-019-44020-w. Sci Rep. 2019. PMID: 31113974 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical